Open1.330 | Close1.250 |
Vol / Avg.437.951K / 2.490M | Mkt Cap8.606M |
Day Range1.220 - 1.360 | 52 Wk Range0.674 - 18.700 |
ABVC BioPharma Stock (NASDAQ: ABVC) stock price, news, charts, stock research, profile.
Open1.330 | Close1.250 |
Vol / Avg.437.951K / 2.490M | Mkt Cap8.606M |
Day Range1.220 - 1.360 | 52 Wk Range0.674 - 18.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.820 | ||||||
REV | 15.884K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.600 | -0.680 | -0.0800 | ||||
REV | 300.000K | 6.109K | -293.891K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2022-11-16 | Maxim Group | Jason McCarthy | Downgrades | BuyHold | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ABVC | ABVC BioPharma | -11.85% | 8.6M |
ERNA | Eterna Therapeutics | -8% | 7.5M |
IMRN | Immuron | 1.9% | 12.2M |
IMPL | Impel Pharmaceuticals | -1.46% | 9.8M |
DOMH | Dominari Holdings | 4.52% | 12.2M |
You can purchase shares of ABVC BioPharma (NASDAQ: ABVC) through any online brokerage.
Other companies in ABVC BioPharma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on Wednesday, November 16, 2022. The analyst firm set a price target for 0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for ABVC BioPharma (NASDAQ: ABVC) is $1.19 last updated Today at December 8, 2023 at 12:40 AM UTC.
There is no dividend information for ABVC BioPharma.
ABVC BioPharma’s Q3 earnings are confirmed for Wednesday, November 15, 2023.
There is no upcoming split for ABVC BioPharma.
ABVC BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.